Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocarditis at the millennium.

C J Hoesley1, C G Cobbs

  • 1University of Alabama at Birmingham, USA.

The Journal of Infectious Diseases
|March 19, 1999
PubMed
Summary
This summary is machine-generated.

Infective endocarditis (IE) management is evolving, with expanding patient demographics and emerging resistant pathogens. New diagnostic and therapeutic strategies are crucial for effective antimicrobial treatment of this complex infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies.

The Journal of hospital infection·2008
Same author

Viral latency--the papillomavirus model.

Developments in biologicals·2002
Same author

Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Effects of a decision support system on physicians' diagnostic performance.

Journal of the American Medical Informatics Association : JAMIA·1999
Same author

Clinical approach to infective endocarditis.

Cardiology clinics·1996
Same author

Cardiac, cerebral, and vascular complications of infective endocarditis.

Cardiology clinics·1996
Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026
Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026
Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026
Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026
Same journal

Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

The Journal of infectious diseases·2026
Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026
See all related articles

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Microbiology

Background:

  • Infective endocarditis (IE) remains a significant clinical challenge.
  • While overall incidence is stable, patient profiles and causative agents are changing.
  • Increasing antibiotic resistance complicates treatment of IE.

Purpose of the Study:

  • To review current understanding of IE pathogenesis.
  • To highlight evolving patient demographics and pathogens.
  • To discuss advancements in diagnostic and therapeutic approaches for IE.

Main Methods:

  • Literature review of recent studies on IE.
  • Analysis of changing trends in IE epidemiology.
  • Synthesis of updated information on antimicrobial therapy and surgical interventions.

Related Experiment Videos

Main Results:

  • The spectrum of patients affected by IE is broadening.
  • Atypical and resistant microorganisms are increasingly implicated in IE cases.
  • New data on IE demographics, diagnostics, and treatments are emerging.

Conclusions:

  • Effective antimicrobial regimens for IE require continuous development.
  • Enhanced diagnostic and surgical strategies are essential for optimal patient care.
  • The infectious diseases community faces ongoing challenges in managing IE effectively.